tiprankstipranks
Advertisement
Advertisement

PCRX Stock Latest News

Pacira Pharmaceuticals Shareholders Back ESPP, Refresh Board Committees
Company AnnouncementsPacira Pharmaceuticals Shareholders Back ESPP, Refresh Board Committees
3d ago
8K
PCRX
Glass Lewis recommends shareholders vote for Pacira director nominees
PremiumThe Fly
Glass Lewis recommends shareholders vote for Pacira director nominees
17d ago
PCRX
Pacira study shows Exparel reduces opioid use and costs
PremiumThe Fly
Pacira study shows Exparel reduces opioid use and costs
19d ago
PCRX
Pacira issues statement on DOMA’s ‘misleading’ statements
PremiumThe Fly
Pacira issues statement on DOMA’s ‘misleading’ statements
20d ago
PCRX
Doma Perpetual urges Pacira shareholders to vote for its board candidates
PremiumThe Fly
Doma Perpetual urges Pacira shareholders to vote for its board candidates
26d ago
PCRX
Doma Perpetual urges Pacira shareholders to vote for its board candidates
PremiumThe FlyDoma Perpetual urges Pacira shareholders to vote for its board candidates
1M ago
PCRX
Pacira Earnings Call Highlights Growth, Pipeline Momentum
Premium
Company Announcements
Pacira Earnings Call Highlights Growth, Pipeline Momentum
1M ago
PCRX
Pacira price target raised to $32 from $30 at Needham
Premium
The Fly
Pacira price target raised to $32 from $30 at Needham
1M ago
PCRX
AI Models Turn More Positive on Pacira Pharmaceuticals as Cash Flow and Balance Sheet Strength Offset Valuation Concerns
PremiumAI Analyst Ratings
AI Models Turn More Positive on Pacira Pharmaceuticals as Cash Flow and Balance Sheet Strength Offset Valuation Concerns
1M ago
PCRX
Pacira reports Q1 EPS 60c, consensus 56c
PremiumThe Fly
Pacira reports Q1 EPS 60c, consensus 56c
2M ago
PCRX
Pacira backs FY26 revenue view $745M-$770M, consensus $760.65M
PremiumThe Fly
Pacira backs FY26 revenue view $745M-$770M, consensus $760.65M
2M ago
PCRX
PCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
PCRX
Exparel’s Proven Clinical and Economic Value Underpins Buy Rating and $38 Price Target on Pacira BioSciences
PremiumRatingsExparel’s Proven Clinical and Economic Value Underpins Buy Rating and $38 Price Target on Pacira BioSciences
2M ago
PCRX
Pacira real-world data clearer in hip arthroplasty, says H.C. Wainwright
Premium
The Fly
Pacira real-world data clearer in hip arthroplasty, says H.C. Wainwright
2M ago
PCRX
Pacira presents data showing lower healthcare costs for Exparel
Premium
The Fly
Pacira presents data showing lower healthcare costs for Exparel
2M ago
PCRX
Pacira price target lowered to $25 from $27 at Barclays
PremiumThe Fly
Pacira price target lowered to $25 from $27 at Barclays
3M ago
PCRX
Doma Perpetual nominates three to Pacira board
PremiumThe Fly
Doma Perpetual nominates three to Pacira board
3M ago
PCRX
Pacira reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Pacira reports inducement grants under Nasdaq listing rule
3M ago
PCRX
Pacira Earnings Call Highlights Margin Gains And Growth
PremiumCompany Announcements
Pacira Earnings Call Highlights Margin Gains And Growth
3M ago
PCRX
Pacira presents evidence real-world evidence from IGOR
PremiumThe FlyPacira presents evidence real-world evidence from IGOR
3M ago
PCRX
Pacira: Conservative 2026 Outlook, Margin Discipline, and NOPAIN Act Tailwinds Support Buy Rating
Premium
Ratings
Pacira: Conservative 2026 Outlook, Margin Discipline, and NOPAIN Act Tailwinds Support Buy Rating
4M ago
PCRX
Pacira reports Q4 EPS 57c, consensus 90c
Premium
The Fly
Pacira reports Q4 EPS 57c, consensus 90c
4M ago
PCRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >